Vastu Vihar Biotech Pvt. Ltd. is a research and product development company affiliated with Technoculture Research, located in Bodhgaya, Bihar. Established in 2011, the company is dedicated to conducting pre-clinical and clinical trials for a pioneering drug utilizing Ribozyme, targeting ailments such as Asthma, Psoriasis, and Chronic Hepatitis. Their mission is to make significant contributions to advancing healthcare, with a focus on combatting prevalent and challenging diseases. VV Biotech has made substantial progress, achieving successful in vivo and in vitro results for various diseases. The company's approach involves testing ribozyme molecules alongside semi-natural lipopeptides vesicles for mRNA cleavage of different chemokines and cytokines. VV Biotech operates within the Agriculture and Biotechnology sectors, with its headquarters in India. Overall, Vastu Vihar Biotech Pvt. Ltd. has positioned itself as a promising player in the biotechnology industry, showcasing notable progress in drug development and research. Their dedication to addressing critical health concerns and achieving tangible results in the form of stable and active drug compounds demonstrates their potential for future growth and impact in the market. As of now, no information regarding their last investment and related investors is available, but the company's compelling dedication to advancing healthcare solutions positions them as a compelling prospect for potential investment within the biotech sector.
There is no investment information
No recent news or press coverage available for Vastu Vihar Biotech Pvt. Ltd..